RxExam NAPLEX Review Theory Part I & Part II 2020-2021 Edition
Click above image to see Naplex Theory Part II.
| Share | |
|---|---|
| Product id: | 032 |
| Author: | Manan Shroff |
| Edition: | 2020-2021 Edition |
| ISBN: | 978-1940835-50-1 |
| Book Formate: | Paperback |
| Pages: | 593 |
| Condition: | New |
| Description: |
Rated
NAPLEX® Preparation Aid By Pharmacy Times
- Covers Updated NAPLEX Competency Statements !
- Over 70 chapters review the basics of pharmacology.
- Well organized therapeutic classifications of drugs at the beginning of each chapter.
- Brand and generic names of medications highly utilized in the U.S.
- Brief review on over-the-counter drugs & TPN.
- Antidotes of medications,normal therapeutic serum concentrations of drugs and much more in easy to read tables.
Retail Price:$100.00
Our Price: $8000
Save:
$20.00 (20%) 20% Save
Customers Who Shopped for RxExam NAPLEX Review Theory Part I & Part II 2020-2021 Edition Also Viewed/Shopped For...
Audio CD ROMS For NAPLEX (10 Cd Roms)
Retail Price:
$200.00
Our Price: $16000
Save: $40.00 (20%)
NAPLEX/FPGEE 30-Minute Review Posters (22 posters)
Retail Price:
$100.00
Our Price: $8000
Save: $20.00 (20%)
RxExam NAPLEX OTC & Herbal Products Flash Cards (200 cards)
Retail Price:
$60.00
Our Price: $5000
Save: $10.00 (16%)
RxExam NAPLEX Review Questions & Answers 2020-2021 Edition
Retail Price:
$75.00
Our Price: $6000
Save: $15.00 (20%)
RxExam NAPLEX RX Flash Cards (400 cards)
Retail Price:
$80.00
Our Price: $7000
Save: $10.00 (12%)
RxExam Pharmaceutical Calculations Review Book 2019-2020 Edition (NAPLEX, FPGEE and PTCE)
Retail Price:
$50.00
Our Price: $4000
Save: $10.00 (20%)
Table Of Contents (Part-1)
Table of Contents (Part II)
- INOTROPIC AGENTS
- ANTIARRHYTHMIC AGENTS
- BETA BLOCKERS
- CENTRALLY ACTING ANTIHYPERTENSIVE
- CA-CHANNEL BLOCKERS
- ACE INHIBITORS
- VASODILATORS
- ANGINA
- DIURETICS
- SPECIFIC ALPHA-1 BLOCKERS
- ANTIHYPERLIPIDEMIC AGENTS
- TRANQUILIZERS & NARCOLEPSY AGENTS
- ANTIEPILEPTICS
- ANTIDEPRESSANTS
- ANTIPARKINSON’S
- ATTENTION DEFICIT HYPERACTIVITY DISORDER
- ANTINEUROLEPTICS
- PENICILLIN
- CEPHALOSPORINS
- ERYTHROMYCIN
- AMINOGLYCOSIDES
- SULFONAMIDES
- QUINOLONES
- TETRACYCLINES
- MISCELLANEOUS ANTIBACTERIAL AGENTS
- ANTI-FUNGAL
- ANTI-VIRAL
- ANTI-TUBERCULOSIS
- ANTI-NEOPLASTIC AGENTS
- TERMINOLY (Antiinfective Agents)
- ACNE PRODUCTS
- ANORECTAL PRODUCTS
- ANTI-ULCER
- ANTI-HISTAMINES
- APPETITE SUPPRESSANTS
- RHEUMATOID ARTHRITIS
- ASTHMA
- BENIGN PROSTATIC HYPERPLASIA
- ERYTHROPOIESIS AND COLONY STIMULATING AGENTS
- HYPERURICEMIA AND GOUT
- IMMUNOSUPPRESSANTS
- ANTI-MIGRAINE
- ANTI-EMETIC AGENTS
- NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
- OPIOID ANALGESICS
- OSTEOPOROSIS AND HYPO/HYPERCALCEMIA
- ANTICOAGULANTS
- THYROID
- DIABETES
- ULCERATIVE COLITIS
- IRRITABLE BOWEL SYNDROME
- ENURESIS/INCONTINENCE MANAGEMENT
- DEMENTIA
- MULTIPLE SCLEROSIS
- MUSCLE RELAXANTS
- CYSTIC FIBROSIS
- ANTI-GLAUCOMA
- ANTI-INFECTIVE OPHTHALAMIC AGENTS
- SMOKING CESSATION AGENTS
- EXPECTORANTS, ANTITUSSIVES, LAXATIVES...
- ACID-BASE DISORDER
- ORAL CONTRACEPTIVES AND IMPOTENCE AGENTS
- PSORIASIS
- VITAMINS AND THEIR SOURCES
- TERATOGENIC DRUGS
- TOTAL PARENTERAL NUTRITION (TPN)
- RENAL FAILURE
- HERBAL DRUGS
- INTERPRETATION OF CLINICAL LABORATORY TESTS
- PHARMACY LAW
- NEW DRUG APPROVAL
- CLINICAL DRUG LITERATURE
- PHARMACOKINETICS